News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
40 Under 40
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
40 Under 40
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
736,380 Results
Type
Article (47320)
Company Profile (365)
Press Release (688695)
Multimedia
Podcasts (99)
Webinars (12)
Section
Business (213635)
Career Advice (2158)
Deals (37140)
Drug Delivery (115)
Drug Development (84279)
Employer Resources (176)
FDA (16799)
Job Trends (15782)
News (361639)
Policy (34718)
Tag
Academia (2708)
Accelerated approval (5)
Adcomms (21)
Allergies (94)
Alliances (52348)
ALS (101)
Alzheimer's disease (1423)
Antibody-drug conjugate (ADC) (153)
Approvals (16791)
Artificial intelligence (289)
Autoimmune disease (26)
Automation (17)
Bankruptcy (380)
Best Places to Work (11957)
BIOSECURE Act (20)
Biosimilars (117)
Biotechnology (239)
Bladder cancer (79)
Brain cancer (29)
Breast cancer (301)
Cancer (2387)
Cardiovascular disease (194)
Career advice (1808)
Career pathing (31)
CAR-T (163)
Cell therapy (456)
Cervical cancer (20)
Clinical research (68468)
Collaboration (892)
Company closure (2)
Compensation (572)
Complete response letters (25)
COVID-19 (2732)
CRISPR (47)
C-suite (265)
Cystic fibrosis (106)
Data (2351)
Decentralized trials (2)
Denatured (34)
Depression (48)
Diabetes (283)
Diagnostics (6572)
Digital health (19)
Diversity (8)
Diversity, equity & inclusion (44)
Drug discovery (125)
Drug pricing (122)
Drug shortages (28)
Duchenne muscular dystrophy (98)
Earnings (89389)
Editorial (44)
Employer branding (22)
Employer resources (150)
Events (118617)
Executive appointments (767)
FDA (18207)
Fibrodysplasia Ossificans Progressiva (1)
Friedreich's ataxia (4)
Frontotemporal dementia (8)
Funding (798)
Gene editing (118)
Generative AI (23)
Gene therapy (340)
GLP-1 (785)
Government (4651)
Grass and pollen (5)
Guidances (158)
Healthcare (19460)
Huntington's disease (25)
IgA nephropathy (28)
Immunology and inflammation (144)
Indications (30)
Infectious disease (2883)
Inflammatory bowel disease (152)
Inflation Reduction Act (9)
Influenza (53)
Intellectual property (100)
Interviews (335)
IPO (16937)
IRA (48)
Job creations (4245)
Job search strategy (1541)
Kidney cancer (10)
Labor market (43)
Layoffs (521)
Leadership (18)
Legal (8710)
Liver cancer (79)
Lung cancer (335)
Lymphoma (159)
Machine learning (9)
Management (59)
Manufacturing (347)
MASH (80)
Medical device (13775)
Medtech (13780)
Mergers & acquisitions (20768)
Metabolic disorders (749)
Multiple sclerosis (87)
NASH (17)
Neurodegenerative disease (101)
Neuropsychiatric disorders (29)
Neuroscience (2010)
NextGen: Class of 2025 (6883)
Non-profit (4655)
Now hiring (41)
Obesity (397)
Opinion (241)
Ovarian cancer (82)
Pain (104)
Pancreatic cancer (89)
Parkinson's disease (155)
Partnered (22)
Patents (253)
Patient recruitment (116)
Peanut (50)
People (60360)
Pharmaceutical (96)
Pharmacy benefit managers (20)
Phase I (21262)
Phase II (30106)
Phase III (22550)
Pipeline (1389)
Policy (164)
Postmarket research (2747)
Preclinical (9144)
Press Release (69)
Prostate cancer (110)
Psychedelics (33)
Radiopharmaceuticals (255)
Rare diseases (412)
Real estate (6519)
Recruiting (68)
Regulatory (23593)
Reports (47)
Research institute (2441)
Resumes & cover letters (364)
Rett syndrome (6)
RNA editing (5)
RSV (44)
Schizophrenia (81)
Series A (140)
Series B (92)
Service/supplier (14)
Sickle cell disease (58)
Special edition (17)
Spinal muscular atrophy (151)
Sponsored (31)
Startups (3836)
State (2)
Stomach cancer (15)
Supply chain (70)
Tariffs (55)
The Weekly (63)
Vaccines (738)
Venture capitalists (44)
Weight loss (268)
Women's health (38)
Worklife (16)
Date
Today (175)
Last 7 days (1002)
Last 30 days (3181)
Last 365 days (33451)
2025 (12195)
2024 (36247)
2023 (41076)
2022 (52249)
2021 (56829)
2020 (55452)
2019 (48286)
2018 (36572)
2017 (33713)
2016 (33479)
2015 (39508)
2014 (33456)
2013 (28639)
2012 (30785)
2011 (31368)
2010 (29521)
Location
Africa (896)
Alabama (60)
Alaska (7)
Arizona (247)
Arkansas (14)
Asia (41913)
Australia (6774)
California (6617)
Canada (2085)
China (561)
Colorado (279)
Connecticut (283)
Delaware (161)
Europe (89399)
Florida (960)
Georgia (216)
Idaho (57)
Illinois (568)
India (26)
Indiana (331)
Iowa (11)
Japan (176)
Kansas (107)
Kentucky (24)
Louisiana (11)
Maine (62)
Maryland (932)
Massachusetts (4870)
Michigan (232)
Minnesota (412)
Mississippi (2)
Missouri (82)
Montana (27)
Nebraska (25)
Nevada (68)
New Hampshire (64)
New Jersey (1817)
New Mexico (29)
New York (1825)
North Carolina (1043)
North Dakota (8)
Northern California (2880)
Ohio (211)
Oklahoma (14)
Oregon (40)
Pennsylvania (1441)
Puerto Rico (14)
Rhode Island (33)
South America (1245)
South Carolina (26)
South Dakota (1)
Southern California (2471)
Tennessee (106)
Texas (968)
United States (24565)
Utah (191)
Virginia (162)
Washington D.C. (66)
Washington State (576)
West Virginia (3)
Wisconsin (60)
736,380 Results for "millennium pharmaceuticals inc south san francisco california".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
DotBio joins JLABS South San Francisco
DotBio has been accepted into Johnson & Johnson’s global incubator network, JLABS South San Francisco.
March 21, 2025
·
1 min read
Press Releases
SIFI announces collaboration with the University of California, San Francisco on Acanthamoeba Keratitis
March 19, 2025
·
5 min read
Press Releases
FairJourney Biologics Acquires Charles River Laboratories South San Francisco Facility
March 4, 2025
·
2 min read
Press Releases
Rivus Pharmaceuticals Expands Leadership Team and Establishes New San Francisco Bay Area Office Ahead of Phase 2 Read-Out in MASH
April 10, 2025
·
7 min read
Biotech Bay
Astellas Unveils New, State-of-the-Art, $90 Million West Coast Innovation Center in the South San Francisco Biotech Corridor
Astellas Pharma Inc. announced the opening of a new $90 million, state-of-the-art center at 480 Forbes Boulevard in South San Francisco, CA.
May 8, 2024
·
3 min read
Press Releases
Integrated DNA Technologies Brings Innovation Nexus to San Francisco Bay Area
May 5, 2025
·
3 min read
Press Releases
University of California San Francisco and GE HealthCare Launch a Joint Research Program to Drive Innovations in Imaging, Brain Health and Precision Oncology
January 15, 2025
·
5 min read
FDA
Biotech Stocks Fall After FDA Names Vinay Prasad To Succeed Marks at CBER
The oncologist and former University of California, San Francisco, professor has long been critical of COVID-19 mandates and the accelerated approval of cancer drugs.
May 6, 2025
·
3 min read
·
Heather McKenzie
Press Releases
Shuttle Pharma Enters into Sponsored Research Agreement with the University of California, San Francisco to Advance PSMA Development Program
December 20, 2024
·
4 min read
Biotech Bay
Nutcracker Therapeutics’ Research Partner, the University of California, San Francisco, Presents Foundational Prostate Cancer Data at AAI 2024
Nutcracker Therapeutics, Inc., a biotechnology company dedicated to developing transformative RNA therapies through its proprietary technology platform, detailed data presented by its partners at the University of California, San Francisco on foundational prostate cancer antigen research utilized to inform the development of its mRNA drug candidate, NTX-470.
May 15, 2024
·
4 min read
1 of 73,638
Next
